Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 198 articles:
HTML format
Text format



Single Articles


    April 2017
  1. VALLIERES E, Tumelty K, Tunney MM, Hannah R, et al
    Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    March 2017
  2. GRAS D, Martinez-Anton A, Bourdin A, Garulli C, et al
    Human bronchial epithelium orchestrates dendritic cell activation in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  3. MUNOZ-CANO R, Torrego A, Bartra J, Sanchez-Lopez J, et al
    Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study).
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  4. DEBRAY MP, Dombret MC, Pretolani M, Thabut G, et al
    Early computed tomography modifications following bronchial thermoplasty in patients with severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  5. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  6. SCAGNOLARI C, Midulla F, Nenna R, Papoff P, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  7. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  8. STERK PJ
    A good asthma catch by professional fishing.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  9. BARALDO S, Papi A, Saetta M, Contoli M, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  10. REINKE SN, Gallart-Ayala H, Gomez C, Checa A, et al
    Metabolomics analysis identifies different metabotypes of asthma severity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  11. PAPI A, Saetta M, Fabbri L
    Severe asthma: phenotyping to endotyping or vice versa?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  12. KUO CS, Pavlidis S, Loza M, Baribaud F, et al
    T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  13. BRUMPTON B, Mai XM, Langhammer A, Laugsand LE, et al
    Prospective study of insomnia and incident asthma in adults: the HUNT study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  14. ZOLLER B, Pirouzifard M, Memon AA, Sundquist J, et al
    Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case-control study from Sweden.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    January 2017
  15. BAHMER T, Waschki B, Schatz F, Herzmann C, et al
    Physical activity, airway resistance and small airway dysfunction in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  16. DE-TORRES JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, et al
    Telomere length, COPD and emphysema as risk factors for lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  17. GRIGG J
    Tiotropium in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  18. ELLWOOD P, Asher MI, Billo NE, Bissell K, et al
    The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available



  19. ERJ January Podcast: the BioSHaRE approach to understanding of the effects of air pollution on asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  20. ALIBERTI S, Dhar R, Aksamit TR, Morgan L, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  21. GUAN WJ, Gao YH, Yuan JJ, Chen RC, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    December 2016
  22. GAGA M, Zervas E, Humbert M
    Targeting immunoglobulin E in non-atopic asthma: crossing the red line?
    Eur Respir J. 2016;48:1538-1540.
    PubMed     Text format    


    November 2016
  23. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2016 Nov 11. pii: ERJ-00969-2016. doi: 10.1183/13993003.00969-2016
    PubMed     Text format     Abstract available


  24. SHIN S, Park HY, Kim H, Kim HK, et al
    Joint effect of airflow limitation and emphysema on postoperative outcomes in early-stage nonsmall cell lung cancer.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01148-2016. doi: 10.1183/13993003.01148-2016.
    PubMed     Text format     Abstract available


  25. HAMELMANN E, Bernstein JA, Vandewalker M, Moroni-Zentgraf P, et al
    A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01100-2016. doi: 10.1183/13993003.01100-2016.
    PubMed     Text format     Abstract available


  26. LEZMI G, Galmiche-Rolland L, Rioux S, Jaubert F, et al
    Mast cells are associated with exacerbations and eosinophilia in children with severe asthma.
    Eur Respir J. 2016;48:1320-1328.
    PubMed     Text format     Abstract available


  27. WILSON SJ, Ward JA, Sousa AR, Corfield J, et al
    Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.
    Eur Respir J. 2016;48:1307-1319.
    PubMed     Text format     Abstract available


  28. FLEMING L, Saglani S, Bush A
    Asthma attacks: should we nail our colours to the mast (cell)?
    Eur Respir J. 2016;48:1261-1264.
    PubMed     Text format    


    October 2016
  29. CAI Y, Zijlema WL, Doiron D, Blangiardo M, et al
    Ambient air pollution, traffic noise and adult asthma prevalence: a BioSHaRE approach.
    Eur Respir J. 2016 Oct 20. pii: ERJ-02127-2015. doi: 10.1183/13993003.02127-2015
    PubMed     Text format     Abstract available


  30. PILLAI P, Chan YC, Wu SY, Ohm-Laursen L, et al
    Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma.
    Eur Respir J. 2016 Oct 20. pii: ERJ-01501-2015. doi: 10.1183/13993003.01501-2015
    PubMed     Text format     Abstract available


  31. CHEN YC, Liou TH, Chen PC, Chiang BL, et al
    Growth trajectories and asthma/rhinitis in children: a longitudinal study in Taiwan.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00741-2016. doi: 10.1183/13993003.00741-2016
    PubMed     Text format     Abstract available


  32. CHEN W, Lynd LD, FitzGerald JM, Marra CA, et al
    Excess medical costs in patients with asthma and the role of comorbidity.
    Eur Respir J. 2016 Oct 6. pii: ERJ-01141-2016. doi: 10.1183/13993003.01141-2016.
    PubMed     Text format     Abstract available


  33. SCHWARZE J, Fitch PM, Heimweg J, Errington C, et al
    Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00841-2016. doi: 10.1183/13993003.00841-2016.
    PubMed     Text format    


  34. MAGNUS MC, Haberg SE, Magnus P, Engeland A, et al
    Pre-eclampsia and childhood asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00673-2016. doi: 10.1183/13993003.00673-2016.
    PubMed     Text format     Abstract available


  35. MAO B, Yang JW, Lu HW, Xu JF, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1247-1248.
    PubMed     Text format    


  36. GAO YH, Guan WJ, Chen RC, Zhang GJ, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1246-1247.
    PubMed     Text format    


  37. POYNTER ME, Irvin CG
    Interleukin-6 as a biomarker for asthma: hype or is there something else?
    Eur Respir J. 2016;48:979-981.
    PubMed     Text format    


  38. HAMBLETON K, Pavord ID
    What can we learn from blood granulocyte patterns in patients with asthma?
    Eur Respir J. 2016;48:976-978.
    PubMed     Text format    


    September 2016
  39. TOMMOLA M, Ilmarinen P, Tuomisto LE, Haanpaa J, et al
    The effect of smoking on lung function: a clinical study of adult-onset asthma.
    Eur Respir J. 2016 Sep 22. pii: ERJ-00850-2016. doi: 10.1183/13993003.00850-2016
    PubMed     Text format     Abstract available



  40. ERJ September Podcast: research priorities in bronchiectasis.
    Eur Respir J. 2016;48:E69.
    PubMed     Text format    


  41. VAN DEN WIJNGAART LS, Roukema J, Merkus PJ
    Monitoring asthma: no matter how?
    Eur Respir J. 2016;48:614-6.
    PubMed     Text format    


  42. ROBINSON DS
    Assessing severe asthma.
    Eur Respir J. 2016;48:611-3.
    PubMed     Text format    


  43. GRAS D, Chanez P
    New sociology for better understanding severe eosinophilic asthma: introducing the SOCS family.
    Eur Respir J. 2016;48:608-10.
    PubMed     Text format    


  44. AHMADIZAR F, Vijverberg SJ, Arets HG, de Boer A, et al
    Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00766-2016. doi: 10.1183/13993003.00766-2016.
    PubMed     Text format     Abstract available


    August 2016
  45. ILMARINEN P, Tuomisto LE, Niemela O, Danielsson J, et al
    Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma.
    Eur Respir J. 2016 Aug 18. pii: ERJ-02198-2015. doi: 10.1183/13993003.02198-2015
    PubMed     Text format     Abstract available


  46. NADIF R, Siroux V, Boudier A, le Moual N, et al
    Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00336-2016. doi: 10.1183/13993003.00336-2016.
    PubMed     Text format     Abstract available


  47. LEHTIMAKI L, Csonka P, Makinen E, Isojarvi J, et al
    Predictive value of exhaled nitric oxide in the management of asthma: a systematic review.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00699-2016. doi: 10.1183/13993003.00699-2016.
    PubMed     Text format     Abstract available


  48. KING GG, Thamrin C
    Complex lung function in severe asthma: seeing is believing.
    Eur Respir J. 2016;48:294-6.
    PubMed     Text format    


  49. PETERS MC, Fahy JV
    Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma.
    Eur Respir J. 2016;48:291-3.
    PubMed     Text format    


  50. BARALDO S, Turato G, Cosio MG, Saetta M, et al
    Which CD8+ T-cells in asthma? Attacking or defending?
    Eur Respir J. 2016;48:287-90.
    PubMed     Text format    


    July 2016
  51. USEMANN J, Fuchs O, Anagnostopoulou P, Korten I, et al
    Predictive value of exhaled nitric oxide in healthy infants for asthma at school age.
    Eur Respir J. 2016 Jul 7. pii: ERJ-00439-2016. doi: 10.1183/13993003.00439-2016.
    PubMed     Text format    



  52. "Tidal flow variability measured by impedance pneumography relates to childhood asthma risk." Ville-Pekka Seppa, Anna S. Pelkonen, Anne Kotaniemi-Syrjanen, Jari Viik, Mika J. Makela and L. Pekka Malmberg. Eur Respir J 2016; 47: 1687-1696.
    Eur Respir J. 2016;48:285.
    PubMed     Text format    


    June 2016
  53. VAN DER MEER AN, Pasma H, Kempenaar-Okkema W, Pelinck JA, et al
    A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00220-2016. doi: 10.1183/13993003.00220-2016
    PubMed     Text format     Abstract available


  54. SIN DD, Miravitlles M, Mannino DM, Soriano JB, et al
    What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00436-2016. doi: 10.1183/13993003.00436-2016
    PubMed     Text format     Abstract available


  55. DORAN E, Choy DF, Shikotra A, Butler CA, et al
    Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00400-2015. doi: 10.1183/13993003.00400-2015
    PubMed     Text format     Abstract available


  56. FISHER JA, Puett RC, Hart JE, Camargo CA Jr, et al
    Particulate matter exposures and adult-onset asthma and COPD in the Nurses' Health Study.
    Eur Respir J. 2016 Jun 10. pii: ERJ-00845-2015. doi: 10.1183/13993003.00845-2015
    PubMed     Text format    


  57. ALIBERTI S, Masefield S, Polverino E, De Soyza A, et al
    Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration.
    Eur Respir J. 2016 Jun 10. pii: ERJ-01888-2015. doi: 10.1183/13993003.01888-2015
    PubMed     Text format     Abstract available



  58. "Asthma inhaler adherence determinants in adults: systematic review of observational data." Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994-1018.
    Eur Respir J. 2016;47:1892.
    PubMed     Text format    


  59. SORIANO JB, Serrano J
    Bronchiectasthma and asthmectasis!
    Eur Respir J. 2016;47:1597-600.
    PubMed     Text format    


    May 2016
  60. DEN OTTER I, Willems LN, van Schadewijk A, van Wijngaarden S, et al
    Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells.
    Eur Respir J. 2016 May 26. pii: ERJ-01525-2015. doi: 10.1183/13993003.01525-2015
    PubMed     Text format     Abstract available


  61. SUBRAMANIAN DR, Gupta S, Burggraf D, Vom Silberberg SJ, et al
    Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.
    Eur Respir J. 2016 May 26. pii: ERJ-01878-2015. doi: 10.1183/13993003.01878-2015
    PubMed     Text format     Abstract available


  62. DUCHARME FM, Gagnon R, Benard B, Tse SM, et al
    Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids.
    Eur Respir J. 2016 May 26. pii: ERJ-00014-2016. doi: 10.1183/13993003.00014-2016
    PubMed     Text format    


  63. VASBINDER EC, Goossens LM, Rutten-van Molken MP, de Winter BC, et al
    e-Monitoring of Asthma Therapy to Improve Compliance in children (e-MATIC): a randomised controlled trial.
    Eur Respir J. 2016 May 26. pii: ERJ-01698-2015. doi: 10.1183/13993003.01698-2015
    PubMed     Text format     Abstract available


  64. CHIH AH, Chen YC, Tu YK, Huang KC, et al
    Mediating pathways from central obesity to childhood asthma: a population-based longitudinal study.
    Eur Respir J. 2016 May 12. pii: ERJ-00226-2016. doi: 10.1183/13993003.00226-2016
    PubMed     Text format     Abstract available


  65. SVENNINGSEN S, Nair P, Guo F, McCormack DG, et al
    Is ventilation heterogeneity related to asthma control?
    Eur Respir J. 2016 May 12. pii: ERJ-00393-2016. doi: 10.1183/13993003.00393-2016
    PubMed     Text format     Abstract available


    April 2016
  66. CARDET JC, Ash S, Kusa T, Camargo CA Jr, et al
    Insulin resistance modifies the association between obesity and current asthma in adults.
    Eur Respir J. 2016 Apr 21. pii: ERJ-00246-2016. doi: 10.1183/13993003.00246-2016
    PubMed     Text format     Abstract available


  67. NANDA CR, Singapuri A, Soares M, Monteiro W, et al
    Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma.
    Eur Respir J. 2016 Apr 21. pii: ERJ-02060-2015. doi: 10.1183/13993003.02060-2015
    PubMed     Text format    


  68. MAO B, Yang JW, Lu HW, Xu JF, et al
    Asthma and bronchiectasis exacerbation.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01862-2015. doi: 10.1183/13993003.01862-2015
    PubMed     Text format     Abstract available


  69. ALIBERTI S, Hill AT, Mantero M, Battaglia S, et al
    Quality standards for the management of bronchiectasis in Italy: a national audit.
    Eur Respir J. 2016 Apr 13. pii: ERJ-00232-2016. doi: 10.1183/13993003.00232-2016
    PubMed     Text format    


  70. PARK HW, Song WJ, Chang YS, Cho SH, et al
    Bronchodilator response following methacholine-induced bronchoconstriction predicts acute asthma exacerbations.
    Eur Respir J. 2016 Apr 13. pii: ERJ-00182-2016. doi: 10.1183/13993003.00182-2016
    PubMed     Text format     Abstract available


  71. BOSNIC-ANTICEVICH SZ
    Asthma management in primary care: caring, sharing and working together.
    Eur Respir J. 2016;47:1043-6.
    PubMed     Text format    


  72. REBER LL, Fahy JV
    Mast cells in asthma: biomarker and therapeutic target.
    Eur Respir J. 2016;47:1040-2.
    PubMed     Text format    


  73. SMITH DJ
    Phenotyping bronchiectasis: is it all about sputum and infection?
    Eur Respir J. 2016;47:1037-9.
    PubMed     Text format    


  74. LUM S, Stocks J
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1292-3.
    PubMed     Text format    


  75. HULS A, Kramer U, Schuster A, Gappa M, et al
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1290-2.
    PubMed     Text format    


  76. GOMEZ C, Chanez P
    The lung microbiome: the perfect culprit for COPD exacerbations?
    Eur Respir J. 2016;47:1034-6.
    PubMed     Text format    


  77. BOUSQUET J, Barbara C, Bateman E, Bel E, et al
    AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.
    Eur Respir J. 2016;47:1028-33.
    PubMed     Text format    


  78. SPRUIT MA, Franssen FM, Rutten EP, Wopereis S, et al
    A new perspective on COPD exacerbations: monitoring impact by measuring physical, psychological and social resilience.
    Eur Respir J. 2016;47:1024-7.
    PubMed     Text format    


  79. COSTA C, Traves SL, Tudhope SJ, Fenwick PS, et al
    Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD.
    Eur Respir J. 2016;47:1093-102.
    PubMed     Text format     Abstract available


  80. CHARUSUSIN N, Gosselink R, McConnell A, Demeyer H, et al
    Inspiratory muscle training improves breathing pattern during exercise in COPD patients.
    Eur Respir J. 2016;47:1261-4.
    PubMed     Text format    


  81. WANG Z, Bafadhel M, Haldar K, Spivak A, et al
    Lung microbiome dynamics in COPD exacerbations.
    Eur Respir J. 2016;47:1082-92.
    PubMed     Text format     Abstract available


  82. DIZIER MH, Nadif R, Margaritte-Jeannin P, Barton SJ, et al
    Interaction between the DNAH9 gene and early smoke exposure in bronchial hyperresponsiveness.
    Eur Respir J. 2016;47:1072-81.
    PubMed     Text format     Abstract available


  83. MUMBY S, Saito J, Adcock IM, Chung KF, et al
    Decreased breath excretion of redox active iron in COPD: a protective failure?
    Eur Respir J. 2016;47:1267-70.
    PubMed     Text format    


    March 2016
  84. PATIL VK, Townshend C, Mitchell F, Kurukulaaratchy RJ, et al
    An outreaching model of tertiary difficult asthma care reduces adverse asthma outcomes and healthcare utilisation costs.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01689-2015. doi: 10.1183/13993003.01689-2015
    PubMed     Text format    


  85. RABINOVICH RA, Miller BE, Wrobel K, Ranjit K, et al
    Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01824-2015. doi: 10.1183/13993003.01824-2015
    PubMed     Text format     Abstract available


  86. SEPPA VP, Pelkonen AS, Kotaniemi-Syrjanen A, Viik J, et al
    Tidal flow variability measured by impedance pneumography relates to childhood asthma risk.
    Eur Respir J. 2016 Mar 17. pii: ERJ-00989-2015. doi: 10.1183/13993003.00989-2015
    PubMed     Text format     Abstract available


  87. BENFANTE A, Battaglia S, Principe S, Di Mitri C, et al
    Asthmatics with high levels of serum surfactant protein D have more severe disease.
    Eur Respir J. 2016 Mar 17. pii: ERJ-02142-2015. doi: 10.1183/13993003.02142-2015
    PubMed     Text format    


  88. KOLAHIAN S, Oz HH, Zhou B, Griessinger CM, et al
    The emerging role of myeloid-derived suppressor cells in lung diseases.
    Eur Respir J. 2016;47:967-77.
    PubMed     Text format     Abstract available


  89. BARTOLI ML, Costa F, Malagrino L, Nieri D, et al
    Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines.
    Eur Respir J. 2016;47:978-80.
    PubMed     Text format    


  90. ZAIGHAM S, Wollmer P, Engstrom G
    Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Eur Respir J. 2016;47:742-50.
    PubMed     Text format     Abstract available


    February 2016
  91. GADE EJ, Thomsen SF, Lindenberg S, Backer V, et al
    Fertility outcomes in asthma: a clinical study of 245 women with unexplained infertility.
    Eur Respir J. 2016 Feb 11. pii: ERJ-01389-2015. doi: 10.1183/13993003.01389-2015
    PubMed     Text format     Abstract available


  92. CONTOLI M, Bellini F, Morandi L, Forini G, et al
    Assessing small airway impairment in mild-to-moderate smoking asthmatic patients.
    Eur Respir J. 2016 Feb 11. pii: ERJ-01708-2015. doi: 10.1183/13993003.01708-2015
    PubMed     Text format    


  93. IERODIAKONOU D, Portelli MA, Postma DS, Koppelman GH, et al
    Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma.
    Eur Respir J. 2016 Feb 11. pii: ERJ-01571-2015. doi: 10.1183/13993003.01571-2015
    PubMed     Text format    


  94. SAMITAS K, Poulos N, Semitekolou M, Morianos I, et al
    Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes.
    Eur Respir J. 2016 Feb 11. pii: ERJ-00437-2015. doi: 10.1183/13993003.00437-2015
    PubMed     Text format     Abstract available


  95. DE VRIES M, Bedke N, Smithers NP, Loxham M, et al
    Inhibition of Pim1 kinase, new therapeutic approach in virus-induced asthma exacerbations.
    Eur Respir J. 2016 Feb 11. pii: ERJ-00171-2015. doi: 10.1183/13993003.00171-2015
    PubMed     Text format     Abstract available


  96. SBIHI H, Tamburic L, Koehoorn M, Brauer M, et al
    Perinatal air pollution exposure and development of asthma from birth to age 10 years.
    Eur Respir J. 2016 Feb 8. pii: ERJ-00746-2015. doi: 10.1183/13993003.00746-2015.
    PubMed     Text format     Abstract available


  97. BEASLEY R, Pavord I, Papi A, Reddel HK, et al
    Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma.
    Eur Respir J. 2016 Feb 4. pii: ERJ-01692-2015. doi: 10.1183/13993003.01692-2015.
    PubMed     Text format    


  98. ALIBERTI S, Lonni S, Dore S, McDonnell MJ, et al
    Clinical phenotypes in adult patients with bronchiectasis.
    Eur Respir J. 2016 Feb 4. pii: ERJ-01899-2015. doi: 10.1183/13993003.01899-2015.
    PubMed     Text format     Abstract available


  99. ESSAT M, Harnan S, Gomersall T, Tappenden P, et al
    Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review.
    Eur Respir J. 2016 Feb 4. pii: ERJ-01882-2015. doi: 10.1183/13993003.01882-2015.
    PubMed     Text format     Abstract available


  100. LEE A, Wright RJ
    Prenatal stress and childhood asthma risk: taking a broader view.
    Eur Respir J. 2016;47:406-9.
    PubMed     Text format    


  101. GUAN WJ, Chen RC, Zhong NS
    The bronchiectasis severity index and FACED score for bronchiectasis.
    Eur Respir J. 2016;47:382-4.
    PubMed     Text format    


  102. SPYCHER BD, Kuehni CE
    Asthma phenotypes in childhood: conceptual thoughts on stability and transition.
    Eur Respir J. 2016;47:362-5.
    PubMed     Text format    


  103. STERK PJ
    Chronic diseases like asthma and COPD: do they truly exist?
    Eur Respir J. 2016;47:359-61.
    PubMed     Text format    


  104. BOLAND AC, Hodgekiss C, Hicks F, Edwards A, et al
    Improving end-of-life communication between primary and secondary care within respiratory medicine.
    Eur Respir J. 2016;47:658-60.
    PubMed     Text format    


  105. MOSS RB
    Treating allergic bronchopulmonary aspergillosis: the way forward.
    Eur Respir J. 2016;47:385-7.
    PubMed     Text format    


  106. SORIANO JB, Suissa S
    Ageing lungs and very elderly COPD: anytime and anywhere.
    Eur Respir J. 2016;47:379-81.
    PubMed     Text format    


  107. LANKEIT M, Held M
    Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?
    Eur Respir J. 2016;47:369-73.
    PubMed     Text format    


  108. AGUSTI A, Bel E, Thomas M, Vogelmeier C, et al
    Treatable traits: toward precision medicine of chronic airway diseases.
    Eur Respir J. 2016;47:410-9.
    PubMed     Text format     Abstract available


  109. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  110. MIRAVITLLES M, Vogelmeier C, Roche N, Halpin D, et al
    A review of national guidelines for management of COPD in Europe.
    Eur Respir J. 2016;47:625-37.
    PubMed     Text format     Abstract available


  111. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


  112. LUOTO JA, Elmstahl S, Wollmer P, Pihlsgard M, et al
    Incidence of airflow limitation in subjects 65-100 years of age.
    Eur Respir J. 2016;47:461-72.
    PubMed     Text format     Abstract available


  113. BORVIK T, Braekkan SK, Enga K, Schirmer H, et al
    COPD and risk of venous thromboembolism and mortality in a general population.
    Eur Respir J. 2016;47:473-81.
    PubMed     Text format     Abstract available


  114. MAGNUSSEN H, Tetzlaff K, Bateman ED, Watz H, et al
    Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.
    Eur Respir J. 2016;47:651-4.
    PubMed     Text format    


  115. GARDEN FL, Simpson JM, Mellis CM, Marks GB, et al
    Change in the manifestations of asthma and asthma-related traits in childhood: a latent transition analysis.
    Eur Respir J. 2016;47:499-509.
    PubMed     Text format     Abstract available


    January 2016
  116. BALBI B, Ferrarotti I, Miravitlles M
    Efficacy of augmentation therapy for emphysema associated with alpha1-antitrypsin deficiency: enough is enough.
    Eur Respir J. 2016;47:35-8.
    PubMed     Text format    


  117. GOEMINNE PC, De Soyza A
    Bronchiectasis: how to be an orphan with many parents?
    Eur Respir J. 2016;47:10-3.
    PubMed     Text format    


  118. ELLIOTT L, von Essen S
    COPD in farmers: what have we learnt?
    Eur Respir J. 2016;47:16-8.
    PubMed     Text format    


  119. SANSORES RH, Ramirez-Venegas A
    COPD in women: susceptibility or vulnerability?
    Eur Respir J. 2016;47:19-22.
    PubMed     Text format    


  120. WELTE T
    Acute exacerbation in COPD: we must do more.
    Eur Respir J. 2016;47:14-5.
    PubMed     Text format    


  121. LAHOUSSE L, Moyse E, Krantic S, Brusselle GG, et al
    Understanding age-related diseases: report of the 2015 Ageing Summit.
    Eur Respir J. 2016;47:5-9.
    PubMed     Text format    


  122. SHAHEEN SO, Macdonald-Wallis C, Lawlor DA, Henderson AJ, et al
    Hypertensive disorders of pregnancy, respiratory outcomes and atopy in childhood.
    Eur Respir J. 2016;47:156-65.
    PubMed     Text format     Abstract available


  123. HARTL S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, et al
    Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.
    Eur Respir J. 2016;47:113-21.
    PubMed     Text format     Abstract available


  124. GUILLIEN A, Puyraveau M, Soumagne T, Guillot S, et al
    Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study.
    Eur Respir J. 2016;47:95-103.
    PubMed     Text format     Abstract available


  125. CURROW DC, Abernethy AP, Allcroft P, Banzett RB, et al
    The need to research refractory breathlessness.
    Eur Respir J. 2016;47:342-3.
    PubMed     Text format    


  126. LEAHY TR, McManus R, Doherty DG, Grealy R, et al
    Interleukin-15 is associated with disease severity in viral bronchiolitis.
    Eur Respir J. 2016;47:212-22.
    PubMed     Text format     Abstract available


  127. LAZAR Z, Mullner N, Lucattelli M, Ayata CK, et al
    NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Eur Respir J. 2016;47:254-63.
    PubMed     Text format     Abstract available


  128. MOTTE S, Melot C, Di Pierdomenico L, Martins D, et al
    Predictors of costs from the hospital perspective of primary pulmonary embolism.
    Eur Respir J. 2016;47:203-11.
    PubMed     Text format     Abstract available


  129. RADEMACHER J, Schulz A, Hedtfeld S, Stanke F, et al
    Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2016;47:322-4.
    PubMed     Text format    


  130. GABROVSKA M, Lacombe E, Bruyneel M, Ninane V, et al
    Acute bronchospasm during passive exposure to bronchial provocation tests.
    Eur Respir J. 2016;47:320-2.
    PubMed     Text format    


  131. YANG JY, Oh SY, Song JW, Shim TS, et al
    Restrictive chronic lung function decline after haematopoietic stem cell transplantation.
    Eur Respir J. 2016;47:336-9.
    PubMed     Text format    


  132. SUISSA S
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:354-5.
    PubMed     Text format    


  133. LETTIS S, Keene O
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:353-4.
    PubMed     Text format    


    December 2015
  134. WANG G, Baines KJ, Fu JJ, Wood LG, et al
    Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma.
    Eur Respir J. 2015 Dec 23. pii: ERJ-01098-2015. doi: 10.1183/13993003.01098-2015
    PubMed     Text format     Abstract available


  135. JOUSILAHTI P, Haahtela T, Laatikainen T, Makela M, et al
    Asthma and respiratory allergy prevalence is still increasing among Finnish young adults.
    Eur Respir J. 2015 Dec 17. pii: ERJ-01702-2015. doi: 10.1183/13993003.01702-2015
    PubMed     Text format    


  136. GARCIA-CARDENAS V, Armour C, Benrimoj SI, Martinez-Martinez F, et al
    Pharmacists' interventions on clinical asthma outcomes: a systematic review.
    Eur Respir J. 2015 Dec 17. pii: ERJ-01497-2015. doi: 10.1183/13993003.01497-2015
    PubMed     Text format     Abstract available


  137. FROIDURE A, Mouthuy J, Durham SR, Chanez P, et al
    Asthma phenotypes and IgE responses.
    Eur Respir J. 2015 Dec 17. pii: ERJ-01824-2014. doi: 10.1183/13993003.01824-2014
    PubMed     Text format     Abstract available


  138. SIMPSON JL, Daly J, Baines KJ, Yang IA, et al
    Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma.
    Eur Respir J. 2015 Dec 2. pii: ERJ-00405-2015. doi: 10.1183/13993003.00405-2015.
    PubMed     Text format     Abstract available


  139. DUIJTS L, Granell R, Sterne JA, Henderson AJ, et al
    Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence.
    Eur Respir J. 2015 Dec 2. pii: ERJ-00718-2015. doi: 10.1183/13993003.00718-2015.
    PubMed     Text format     Abstract available


  140. TAN NC, Nguyen HV, Lye WK, Sankari U, et al
    Trends and predictors of asthma costs: results from a 10-year longitudinal study.
    Eur Respir J. 2015 Dec 2. pii: ERJ-00188-2015. doi: 10.1183/13993003.00188-2015.
    PubMed     Text format     Abstract available


  141. POPOVIC M, Rusconi F, Zugna D, Galassi C, et al
    Prenatal exposure to antibiotics and wheezing in infancy: a birth cohort study.
    Eur Respir J. 2015 Dec 2. pii: ERJ-00315-2015. doi: 10.1183/13993003.00315-2015.
    PubMed     Text format     Abstract available


    November 2015
  142. AGARWAL R, Aggarwal AN, Dhooria S, Singh Sehgal I, et al
    A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2015 Nov 19. pii: ERJ-01475-2015. doi: 10.1183/13993003.01475-2015
    PubMed     Text format     Abstract available


  143. ELLIS HC, Cowman S, Fernandes M, Wilson R, et al
    Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study.
    Eur Respir J. 2015 Nov 19. pii: ERJ-01312-2015. doi: 10.1183/13993003.01312-2015
    PubMed     Text format     Abstract available


  144. QUINT JK, Millett ER, Joshi M, Navaratnam V, et al
    Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study.
    Eur Respir J. 2015 Nov 5. pii: ERJ-01033-2015. doi: 10.1183/13993003.01033-2015.
    PubMed     Text format     Abstract available


  145. HARDIN M, Foreman M, Dransfield MT, Hansel N, et al
    Sex-specific features of emphysema among current and former smokers with COPD.
    Eur Respir J. 2015 Nov 5. pii: ERJ-00996-2015. doi: 10.1183/13993003.00996-2015.
    PubMed     Text format     Abstract available


  146. VAN DE LOO KF, van Gelder MM, Roukema J, Roeleveld N, et al
    Prenatal maternal psychological stress and childhood asthma and wheezing: a meta-analysis.
    Eur Respir J. 2015 Nov 5. pii: ERJ-00299-2015. doi: 10.1183/13993003.00299-2015.
    PubMed     Text format     Abstract available


  147. SAGLANI S, Lloyd CM
    Novel concepts in airway inflammation and remodelling in asthma.
    Eur Respir J. 2015 Nov 5. pii: ERJ-01196-2014. doi: 10.1183/13993003.01196-2014.
    PubMed     Text format     Abstract available


  148. YEATTS K
    "Health consequences associated with frequent wheezing in adolescents without asthma diagnosis." K. Yeatts, K. Johnston Davis, D. Peden and C. Shy. Eur Respir J 2003; 22: 781-786.
    Eur Respir J. 2015;46:1532.
    PubMed     Text format    



  149. ERJ November Podcast: results from the adult and paediatric cohorts of the U-BIOPRED study of severe asthma.
    Eur Respir J. 2015;46:E59.
    PubMed     Text format    


  150. BOULET LP
    Asthma education: an essential component in asthma management.
    Eur Respir J. 2015;46:1262-4.
    PubMed     Text format    


  151. GAGA M, Brand PL, Thomson NC
    The quest for the grail: multidimensional efforts for understanding and targeting severe asthma.
    Eur Respir J. 2015;46:1227-31.
    PubMed     Text format    


  152. CELLI BR
    We must join forces in the battle against COPD.
    Eur Respir J. 2015;46:1528.
    PubMed     Text format    


  153. OSTREM A, Williams S, Pinnock H
    We must join forces in the battle against COPD.
    Eur Respir J. 2015;46:1526-8.
    PubMed     Text format    


  154. CELLI BR
    COPD (confusion over proper diagnosis) in the zone of maximum uncertainty.
    Eur Respir J. 2015;46:1525-6.
    PubMed     Text format    


  155. QUANJER PH, Ruppel G, Brusasco V, Perez-Padilla R, et al
    COPD (confusion over proper diagnosis) in the zone of maximum uncertainty.
    Eur Respir J. 2015;46:1523-4.
    PubMed     Text format    


    October 2015
  156. COX DW, Mullane D, Zhang GC, Turner SW, et al
    Longitudinal assessment of airway responsiveness from 1 month to 18 years in the PIAF birth cohort.
    Eur Respir J. 2015 Oct 22. pii: ERJ-00397-2015. doi: 10.1183/13993003.00397-2015
    PubMed     Text format     Abstract available


  157. YAMMINE S, Schmidt A, Sutter O, Fouzas S, et al
    Functional evidence for continued alveolarisation in former preterms at school age?
    Eur Respir J. 2015 Oct 22. pii: ERJ-00478-2015. doi: 10.1183/13993003.00478-2015
    PubMed     Text format     Abstract available


    September 2015
  158. ALMAGRO P, Cabrera FJ, Diez-Manglano J, Boixeda R, et al
    Comorbidome and short-term prognosis in hospitalised COPD patients: the ESMI study.
    Eur Respir J. 2015;46:850-3.
    PubMed     Text format    


    August 2015
  159. MCKEON NJ, Timmins SN, Stewart H, Yerkovich ST, et al
    Diagnosis of COPD before cardiac surgery.
    Eur Respir J. 2015 Aug 20. pii: ERJ-02339-2014. doi: 10.1183/13993003.02339-2014
    PubMed     Text format    


    July 2015
  160. GAUVREAU GM, El-Gammal AI, O'Byrne PM
    Allergen-induced airway responses.
    Eur Respir J. 2015 Jul 23. pii: ERJ-00536-2015. doi: 10.1183/13993003.00536-2015
    PubMed     Text format     Abstract available


  161. HIROTA JA, Carlsten C, Sadatsafavi M, Kaplan G, et al
    Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?
    Eur Respir J. 2015;46:287-8.
    PubMed     Text format    


    June 2015
  162. DE SOYZA A, Calverley PM
    Large trials, new knowledge: the changing face of COPD management.
    Eur Respir J. 2015;45:1692-703.
    PubMed     Text format     Abstract available


  163. LUM S, Bountziouka V, Sonnappa S, Cole TJ, et al
    How "healthy" should children be when selecting reference samples for spirometry?
    Eur Respir J. 2015;45:1576-81.
    PubMed     Text format     Abstract available


  164. LAUCHO-CONTRERAS ME, Polverino F, Gupta K, Taylor KL, et al
    Protective role for club cell secretory protein-16 (CC16) in the development of COPD.
    Eur Respir J. 2015;45:1544-56.
    PubMed     Text format     Abstract available


  165. BAUDISS K, Ayata CK, Lazar Z, Cicko S, et al
    Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation.
    Eur Respir J. 2015;45:1669-80.
    PubMed     Text format     Abstract available


    May 2015
  166. CLARK TW
    Are C-reactive protein levels associated with bacteria in COPD exacerbations?
    Eur Respir J. 2015;45:1515-6.
    PubMed     Text format    


  167. MIRAVITLLES M, Llor C
    Are C-reactive protein levels associated with bacteria in COPD exacerbations?
    Eur Respir J. 2015;45:1514-5.
    PubMed     Text format    


    April 2015
  168. KAUCZOR HU, Bonomo L, Gaga M, Nackaerts K, et al
    ESR/ERS white paper on lung cancer screening.
    Eur Respir J. 2015 Apr 30. pii: ERJ-00330-2015.
    PubMed     Text format     Abstract available


  169. CELLI BR, Decramer M, Wedzicha JA, Wilson KC, et al
    An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.
    Eur Respir J. 2015;45:879-905.
    PubMed     Text format     Abstract available


  170. SUISSA S
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2015;45:875-8.
    PubMed     Text format    


  171. HIEMSTRA PS, McCray PB Jr, Bals R
    The innate immune function of airway epithelial cells in inflammatory lung disease.
    Eur Respir J. 2015;45:1150-62.
    PubMed     Text format     Abstract available


  172. LEUNG JM, Mayo J, Tan W, Tammemagi CM, et al
    Plasma pro-surfactant protein B and lung function decline in smokers.
    Eur Respir J. 2015;45:1037-45.
    PubMed     Text format     Abstract available


  173. BUHL R, Maltais F, Abrahams R, Bjermer L, et al
    Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
    Eur Respir J. 2015;45:969-79.
    PubMed     Text format     Abstract available


  174. MANNINO DM
    Biomarkers in COPD: the search continues!
    Eur Respir J. 2015;45:872-4.
    PubMed     Text format    


  175. RABE KF
    Treatment of COPD and the TOnado trial: a tempest in a teapot?
    Eur Respir J. 2015;45:869-71.
    PubMed     Text format    


  176. LADJEMI MZ, Lecocq M, Weynand B, Bowen H, et al
    Increased IgA production by B-cells in COPD via lung epithelial interleukin-6 and TACI pathways.
    Eur Respir J. 2015;45:980-93.
    PubMed     Text format     Abstract available


  177. BRASSARD P, Vutcovici M, Ernst P, Patenaude V, et al
    Increased incidence of inflammatory bowel disease in Quebec residents with airway diseases.
    Eur Respir J. 2015;45:962-8.
    PubMed     Text format     Abstract available


    March 2015
  178. ANNESI-MAESANO I
    It is not time to lower the guard!
    Eur Respir J. 2015;45:589-91.
    PubMed     Text format    


  179. MEINERS S, Eickelberg O, Konigshoff M
    Hallmarks of the ageing lung.
    Eur Respir J. 2015;45:807-27.
    PubMed     Text format     Abstract available


  180. MOHAMED HOESEIN FA, de Jong PA, Lammers JW, Mali WP, et al
    Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation.
    Eur Respir J. 2015;45:644-51.
    PubMed     Text format     Abstract available


  181. BARNES PJ
    Mechanisms of development of multimorbidity in the elderly.
    Eur Respir J. 2015;45:790-806.
    PubMed     Text format     Abstract available


  182. PISANI L, Mega C, Vaschetto R, Bellone A, et al
    Oronasal mask versus helmet in acute hypercapnic respiratory failure.
    Eur Respir J. 2015;45:691-9.
    PubMed     Text format     Abstract available


  183. AARLI BB, Calverley PM, Jensen RL, Eagan TM, et al
    Variability of within-breath reactance in COPD patients and its association with dyspnoea.
    Eur Respir J. 2015;45:625-34.
    PubMed     Text format     Abstract available


  184. MAKINSON A, Hayot M, Eymard-Duvernay S, Quesnoy M, et al
    High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers.
    Eur Respir J. 2015;45:828-31.
    PubMed     Text format    


    February 2015
  185. FENG JY, Chen SC, Lee MC, Fan WC, et al
    Is 1-year follow-up adequate for adult tuberculosis contacts?
    Eur Respir J. 2015 Feb 19. pii: ERJ-01421-2014.
    PubMed     Text format    


  186. FUKIHARA J, Kondoh Y, Taniguchi H, Kimura T, et al
    Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease.
    Eur Respir J. 2015 Feb 5. pii: ERJ-01303-2014.
    PubMed     Text format    


    January 2015
  187. PIJNENBURG MW, Merkus PJ
    NO kidding: exhaled nitric oxide fraction in preschool children.
    Eur Respir J. 2015;45:30-2.
    PubMed     Text format    


  188. VANFLETEREN LE
    Does COPD stand for "COmorbidity with Pulmonary Disease"?
    Eur Respir J. 2015;45:14-7.
    PubMed     Text format    


  189. MAROZKINA NV, Wang XQ, Stsiapura V, Fitzpatrick A, et al
    Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity.
    Eur Respir J. 2015;45:87-97.
    PubMed     Text format     Abstract available


  190. ROCHE N, Jebrak G, Caillaud D, Deslee G, et al
    Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment.
    Eur Respir J. 2015;45:260-2.
    PubMed     Text format    


  191. PIZARRO C, Ahmadzadehfar H, Essler M, Fimmers R, et al
    Volumetric and scintigraphic changes following endoscopic lung volume reduction.
    Eur Respir J. 2015;45:262-5.
    PubMed     Text format    


  192. LEMIERE C, To T, de Olim C, Ribeiro M, et al
    Outcome of work-related asthma exacerbations in Quebec and Ontario.
    Eur Respir J. 2015;45:266-8.
    PubMed     Text format    


  193. CHANG D, Yao W, Tiller CJ, Kisling J, et al
    Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity.
    Eur Respir J. 2015;45:98-106.
    PubMed     Text format     Abstract available


  194. DIJKSTRA AE, Boezen HM, van den Berge M, Vonk JM, et al
    Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD.
    Eur Respir J. 2015;45:60-75.
    PubMed     Text format     Abstract available


  195. BOUTIN B, Koskas M, Guillo H, Maingot L, et al
    Forced expiratory flows' contribution to lung function interpretation in schoolchildren.
    Eur Respir J. 2015;45:107-15.
    PubMed     Text format     Abstract available


  196. CLARK TW, Medina MJ, Batham S, Curran MD, et al
    C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD.
    Eur Respir J. 2015;45:76-86.
    PubMed     Text format     Abstract available


  197. GERSHON AS, Mecredy GC, Guan J, Victor JC, et al
    Quantifying comorbidity in individuals with COPD: a population study.
    Eur Respir J. 2015;45:51-9.
    PubMed     Text format     Abstract available


  198. MORISSETTE MC, Shen P, Thayaparan D, Stampfli MR, et al
    Impacts of peroxisome proliferator-activated receptor-gamma activation on cigarette smoke-induced exacerbated response to bacteria.
    Eur Respir J. 2015;45:191-200.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: